AIF1 and neoplasm: Interestingly, MCT-treated tumors showed a significant increase in tumor-infiltrating CD3+ lymphocytes (TIL) (Supplementary Fig. 1d) with evident “hotspot” areas with spatially proximal Iba1+ myeloid cells and CD3+ TIL (Fig. 1c).